Abstract
This new report has been written to provide members of pharmaceutical,
biotechnology and clinical research sectors an analytically-based overview of
the mechanisms of the partnering process, and the key issues and trends
affecting these arrangements.
The modern pharmaceutical company faces numerous challenges in its efforts to
improve productivity and to strengthen the product portfolio. In an attempt to
counteract the pressures of operating in a global pharmaceutical market,
companies have sought to establish relationships with external partners such
as biotechnology companies and Clinical Research Organizations (CROs) as a
means to remaining competitive and profitable.
Alliances and external collaborations have provided companies with the
opportunity to gain access to new technological breakthroughs and novel
expertise regardless of national or geographical boundaries. Evidence of the
growing emphasis on alliances and external collaborations as a route to
success is highlighted by the fact that partnerships within the
biopharmaceutical sector are currently being formed at the rate of $5 billion
per year.
This new report is designed to provide information, insight and in-depth
analysis of alliance and licensing activity within the pharmaceutical industry
in order to identify the challenges faced by members of the pharmaceutical
community; current trends in partnering activity; an understanding of the
dynamics of the buyer-supplier relationship and best practices for managing
external collaborations. The report is aimed at providing an appraisal of the
partnering process, and insights into the current environment of
pharmaceutical discovery and development.
Strategies for Innovation in Pharmaceutical R&D includes the following
features:
- A thorough market analysis of the global pharmaceutical industry,
including the challenges faced by pharmaceutical manufacturers and the
technological developments currently affecting innovation
- A review of key developments taking place in the environment of
pharmaceutical R&D and an evaluation of possible strategies for facilitating
the drug discovery and development process
- Analysis of the significance of biotechnology to the pharmaceutical
industry, including key trends in pharmaceutical alliance and licensing
agreements
- An assessment of the importance of outsourcing to the drug development
process, and an overview of the market for contract research, including key
trends in pharmaceutical licensing agreements
- Guidelines for partnership management, with profiles of market leaders in
the areas of pharmaceuticals, biotechnology and clinical research
- An informative and vital source of reference that provides practitioners
with easy to access case studies, tabular data, key competitor profiles and a
glossary of key pharmaceutical terms and definitions, with details of
alliance and licensing deals within the biopharmaceutical sector
View Cart
